Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT02473211 Completed - Clinical trials for Chronic Hepatitis C Infection

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

Start date: January 2015
Phase: Phase 2/Phase 3
Study type: Interventional

For those chronic hepatitis C patients, who are interferon-ineligible or intolerant, there is a burning need for the development of pan-oral interferon-free regimen. The investigators examine the efficacy and safety of sofosbuvir, a NS5B nucleotide polymerase inhibitor and daclatasvir, an NS5A replication complex inhibitor in Chinese treatment-experienced cirrhosis patients with chronic G1b infection.

NCT ID: NCT02472886 Completed - Clinical trials for Hepatitis C Virus Infection

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Start date: June 17, 2015
Phase: Phase 3
Study type: Interventional

The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed dose combination (FDC) with or without ribavirin (RBV) in adults with chronic hepatitis C virus (HCV) infection.

NCT ID: NCT02470208 Completed - Infection Clinical Trials

Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation

REACT
Start date: June 2015
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the ability of the T-SPOT.CMV assay to determine immune competence against CMV infection in stem cell transplantation. To determine the utility of the T-SPOT.CMV assay used before transplantation to determine immune competence against subsequent CMV reactivation and to determine the utility of the T-SPOT.CMV assay used after transplantation to determine immune competence against subsequent CMV reactivation.

NCT ID: NCT02467439 Completed - Clinical trials for Sexually Transmitted Infections

Acute Partner and Social Contact Referral: iKnow

Start date: June 2015
Phase: N/A
Study type: Interventional

The primary purpose of this research is to assess the benefit of an "unaware intervention package" for identifying high risk persons who are unaware of their HIV infection status. This intervention package includes screening for acute HIV infection, contract sexual partner referral, and peer referral.

NCT ID: NCT02467049 Completed - Cancer Clinical Trials

ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip

Start date: June 2015
Phase: N/A
Study type: Interventional

In the prevention of thrombosis related to catheter placement it is important to have a right position of the catheter tip. Therefor we want to assess which technique is the most successful in the placing of a PICC.

NCT ID: NCT02463214 Completed - Clinical trials for Transplantation Infection

Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients

Start date: September 2015
Phase: N/A
Study type: Interventional

This study involves sampling bone marrow transplant patients, hospital workers and the patient room for microbes using swabs and other techniques. We send these samples to the laboratory, where they will use state-of-the art technology to identify and relate the microbes to each other. This study also involves putting copper, nickel, or titanium into some hospital rooms, and seeing whether these metals influences the growth of microbes. Some equipment in the hospital room, such as faucets and soap dispensers will be replaced by sensor-based (e.g. touchless) controls.

NCT ID: NCT02461901 Completed - Clinical trials for Clostridium Difficile Infection

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Start date: January 2015
Phase:
Study type: Observational

This study evaluates whether patients with Clostridium difficile infection (CDI) who are treated with fidaxomicin have less contamination of their skin and surrounding environment with spores of C. difficile than patients treated with other drugs (metronidazole or vancomycin)

NCT ID: NCT02457611 Completed - Clinical trials for Hepatitis C Infection With HIV Co-Infection

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Start date: June 2015
Phase: Phase 2
Study type: Interventional

The primary objectives of this study are to determine the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) in adults with acute genotype 1 or 4 hepatitis C virus (HCV) and chronic human immunodeficiency virus (HIV)-1 co-infection.

NCT ID: NCT02453789 Completed - Cystic Fibrosis Clinical Trials

A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

SMR-2591
Start date: February 2015
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess the efficacy of Alginate oligosaccharide (OligoG) dry powder for inhalation in cystic fibrosis (CF) patients with a Burkholderia spp. infection.

NCT ID: NCT02452216 Completed - Brain Cancer Clinical Trials

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Start date: June 10, 2015
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial study will assess the inflammatory response of brain tumors or other central nervous system conditions in pediatric and adult patients using ferumoxytol-enhanced MRI. Imaging features will be correlated with the number of inflammatory cells (macrophages) at histopathology. Determining the extent of inflammation associated with pathologies in the central nervous system may be helpful for diagnostic and prognostic purposes as well as monitoring treatment response of current and future immunotherapies.